233 related articles for article (PubMed ID: 19589922)
1. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
[TBL] [Abstract][Full Text] [Related]
2. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors.
Niewerth M; Kunze D; Seibold M; Schaller M; Korting HC; Hube B
Antimicrob Agents Chemother; 2003 Jun; 47(6):1805-17. PubMed ID: 12760852
[TBL] [Abstract][Full Text] [Related]
3. The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
Linden T; Katschinski DM; Eckhardt K; Scheid A; Pagel H; Wenger RH
FASEB J; 2003 Apr; 17(6):761-3. PubMed ID: 12594177
[TBL] [Abstract][Full Text] [Related]
4. The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.
Weir SJ; Patton L; Castle K; Rajewski L; Kasper J; Schimmer AD
J Clin Pharm Ther; 2011 Apr; 36(2):128-34. PubMed ID: 21366640
[TBL] [Abstract][Full Text] [Related]
5. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
[TBL] [Abstract][Full Text] [Related]
6. Repositioning the Old Fungicide Ciclopirox for New Medical Uses.
Shen T; Huang S
Curr Pharm Des; 2016; 22(28):4443-50. PubMed ID: 27238364
[TBL] [Abstract][Full Text] [Related]
7. Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease.
Radadiya PS; Thornton MM; Puri RV; Yerrathota S; Dinh-Phan J; Magenheimer B; Subramaniam D; Tran PV; Zhu H; Bolisetty S; Calvet JP; Wallace DP; Sharma M
JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33784251
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
9. The antitumor activity of the fungicide ciclopirox.
Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S
Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320
[TBL] [Abstract][Full Text] [Related]
10. Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.
Sen S; Hassane DC; Corbett C; Becker MW; Jordan CT; Guzman ML
Exp Hematol; 2013 Sep; 41(9):799-807.e4. PubMed ID: 23660068
[TBL] [Abstract][Full Text] [Related]
11. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.
Minden MD; Hogge DE; Weir SJ; Kasper J; Webster DA; Patton L; Jitkova Y; Hurren R; Gronda M; Goard CA; Rajewski LG; Haslam JL; Heppert KE; Schorno K; Chang H; Brandwein JM; Gupta V; Schuh AC; Trudel S; Yee KW; Reed GA; Schimmer AD
Am J Hematol; 2014 Apr; 89(4):363-8. PubMed ID: 24273151
[TBL] [Abstract][Full Text] [Related]
12. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
[TBL] [Abstract][Full Text] [Related]
13. Translational downregulation of HSP90 expression by iron chelators in neuroblastoma cells.
Sidarovich V; Adami V; Gatto P; Greco V; Tebaldi T; Tonini GP; Quattrone A
Mol Pharmacol; 2015; 87(3):513-24. PubMed ID: 25564462
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt/beta-catenin pathway in multiple myeloma.
Schmeel LC; Schmeel FC; Kim Y; Endo T; Lu D; Schmidt-Wolf IG
Anticancer Res; 2013 Nov; 33(11):4719-26. PubMed ID: 24222106
[TBL] [Abstract][Full Text] [Related]
15. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
16. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
Huang Z; Huang S
Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
[TBL] [Abstract][Full Text] [Related]
17. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.
Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S
Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
Kim Y; Schmidt M; Endo T; Lu D; Carson D; Schmidt-Wolf IG
In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681
[TBL] [Abstract][Full Text] [Related]
19. The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma.
Kamihara Y; Takada K; Sato T; Kawano Y; Murase K; Arihara Y; Kikuchi S; Hayasaka N; Usami M; Iyama S; Miyanishi K; Sato Y; Kobune M; Kato J
Oncotarget; 2016 Sep; 7(39):64330-64341. PubMed ID: 27602957
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Zarember KA; Cruz AR; Huang CY; Gallin JI
Antimicrob Agents Chemother; 2009 Jun; 53(6):2654-6. PubMed ID: 19307370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
